Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus.
Samuelsen. Orjan O; Haukland. Hanne H HH; Jenssen. Håvard H; Krämer. Manuela M; Sandvik. Kjersti K; Ulvatne. Hilde H; Vorland. Lars H LH
Key Findings
- Repeated exposure to lactoferricin B can induce resistance in Staph aureus
- The induced resistance is unstable and drops off without the peptide
- No cross‑resistance to the human cathelicidin LL‑37 was observed
Practical Outcomes
- For DIY health enthusiasts, this suggests that using LL‑37 as an antimicrobial is less likely to drive bacterial resistance, but relying on lactoferricin B could lead to temporary resistance. Rotate or limit exposure to lactoferricin B to avoid reduced effectiveness.
Summary
The study found that Staph bacteria can become resistant to the antimicrobial peptide lactoferricin B when repeatedly exposed, but this resistance fades when the peptide is removed and the bacteria do not become resistant to the human peptide LL‑37.
Abstract
This study was designed to investigate inducible intrinsic resistance against lactoferricin B in Staphylococcus aureus. Serial passage of seven S. aureus strains in medium with increasing concentrations of peptide resulted in an induced resistance at various levels in all strains. The induced resistance was unstable and decreased relatively rapidly during passages in peptide free medium but the minimum inhibitory concentration remained elevated after thirty passages. Cross-resistance to penicillin G and low-level cross-resistance to the antimicrobial peptides indolicidin and Ala(8,13,18)-magainin-II amide [corrected] was observed. No cross-resistance was observed to the human cathelicidin LL-37. In conclusion, this study shows that S. aureus has intrinsic resistance mechanisms against antimicrobial peptides that can be induced upon exposure, and that this may confer low-level cross-resistance to other antimicrobial peptides.
Study Information
pubmed
2005
2005-06-20T00:00:00.000Z
10.1016/j.febslet.2005.05.017
47
41